Sanofi
SNY
SNY
717 hedge funds and large institutions have $12.8B invested in Sanofi in 2024 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 247 increasing their positions, 279 reducing their positions, and 91 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% less funds holding in top 10
Funds holding in top 10: 13 → 11 (-2)
15% less first-time investments, than exits
New positions opened: 77 | Existing positions closed: 91
21% less capital invested
Capital invested by funds: $16.3B → $12.8B (-$3.49B)
Holders
717
Holding in Top 10
11
Calls
$94.5M
Puts
$74.6M
Top Buyers
| 1 | +$246M | |
| 2 | +$121M | |
| 3 | +$82.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$41.6M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$36.8M |
Top Sellers
| 1 | -$371M | |
| 2 | -$315M | |
| 3 | -$176M | |
| 4 |
BlackRock
New York
|
-$128M |
| 5 |
Millennium Management
New York
|
-$118M |